LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 9 of 15: Cell count and normalized growth rate inhibition values within biological replicate 2. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 9 of 15: Cell count and normalized growth rate inhibition values within biological replicate 2. - Dataset (ID:20246)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells

|<
<<
Previous
Page 331 of 520
Next
>>
>
8251 to 8275 of 12982 records
per page:

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Replicate	Assay Well	Timepoint	Timepoint Unit	Total Cell Count Before Treatment	Total Cell Count After Treatment	Total Control Cell Count	Relative Cell Count	Normalized Growth Rate Inhibition Value
BT-20	GDC-0980	0.04	uM	LJP5	3	K24	72	hr	1334	2402	4117	0.5833	0.4355
BT-20	GDC-0980	0.12	uM	LJP5	1	K23	72	hr	1334	1634	3930	0.4157	0.1387
BT-20	GDC-0980	0.12	uM	LJP5	2	K23	72	hr	1334	1417	4051	0.3498	0.0381
BT-20	GDC-0980	0.12	uM	LJP5	3	K23	72	hr	1334	1610	4117	0.3910	0.1223
BT-20	GDC-0980	0.37	uM	LJP5	1	K22	72	hr	1334	1190	3930	0.3027	-0.0710
BT-20	GDC-0980	0.37	uM	LJP5	2	K22	72	hr	1334	1244	4051	0.3071	-0.0430
BT-20	GDC-0980	0.37	uM	LJP5	3	K22	72	hr	1334	1142	4117	0.2773	-0.0915
BT-20	GDC-0980	1.11	uM	LJP5	1	K21	72	hr	1334	987	3930	0.2511	-0.1761
BT-20	GDC-0980	1.11	uM	LJP5	2	K21	72	hr	1334	994	4051	0.2454	-0.1681
BT-20	GDC-0980	1.11	uM	LJP5	3	K21	72	hr	1334	1003	4117	0.2436	-0.1612
BT-20	GDC-0980	3.33	uM	LJP5	1	K20	72	hr	1334	934	3930	0.2376	-0.2047
BT-20	GDC-0980	3.33	uM	LJP5	2	K20	72	hr	1334	924	4051	0.2281	-0.2051
BT-20	GDC-0980	3.33	uM	LJP5	3	K20	72	hr	1334	834	4117	0.2025	-0.2512
BT-20	GDC-0980	10	uM	LJP5	1	K19	72	hr	1334	883	3930	0.2246	-0.2329
BT-20	GDC-0980	10	uM	LJP5	2	K19	72	hr	1334	888	4051	0.2192	-0.2246
BT-20	GDC-0980	10	uM	LJP5	3	K19	72	hr	1334	802	4117	0.1948	-0.2690
BT-20	Mitoxantrone	0.04	uM	LJP6	1	C24	72	hr	1334	1660	3955	0.4196	0.1493
BT-20	Mitoxantrone	0.04	uM	LJP6	2	C24	72	hr	1334	2348	3899	0.6022	0.4408
BT-20	Mitoxantrone	0.04	uM	LJP6	3	C24	72	hr	1334	2673	3921	0.6817	0.5631
BT-20	Mitoxantrone	0.04	uM	LJP5	1	C24	72	hr	1334	1308	3930	0.3328	-0.0129
BT-20	Mitoxantrone	0.04	uM	LJP5	2	C24	72	hr	1334	1636	4051	0.4038	0.1355
BT-20	Mitoxantrone	0.04	uM	LJP5	3	C24	72	hr	1334	1781	4117	0.4325	0.1942
BT-20	Mitoxantrone	0.12	uM	LJP6	1	C23	72	hr	1334	1187	3955	0.3001	-0.0721
BT-20	Mitoxantrone	0.12	uM	LJP6	2	C23	72	hr	1334	1589	3899	0.4075	0.1194
BT-20	Mitoxantrone	0.12	uM	LJP6	3	C23	72	hr	1334	1804	3921	0.4600	0.2138

|<
<<
Previous
Page 331 of 520
Next
>>
>
8251 to 8275 of 12982 records
per page:

HMS LINCS Project

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 9 of 15: Cell count and normalized growth rate inhibition values within biological replicate 2. - Dataset (ID:20246)